We are an innovative biopharmaceutical company developing therapies to treat the mitochondrial dysfunction associated with genetic mitochondrial diseases and many common age-related diseases. Our mission is to lead the development of mitochondrial medicine to improve the lives of patients with diseases involving mitochondrial dysfunction, an area of high unmet clinical need.
We are invested in patient-focused therapeutic development and driven by a desire to help patients with unmet clinical needs. Our team brings a wealth of executive experience in their respective fields to Stealth BioTherapeutics.
We are an innovative biopharmaceutical company developing therapies to treat mitochondrial dysfunction associated with genetic mitochondrial diseases and common diseases of aging. Our team works with patients and advocacy organizations to better understand their journey and raise awareness of the unmet clinical needs our programs seek to address.
We collaborate with top-tier academic and medical institutions, scientific thought leaders, and clinical key opinion leaders in developing the first generation of targeted therapies focusing on mitochondrial dysfunction as it presents in these rare genetic diseases and common diseases of aging. With these collaborative efforts, we continue to advance our platform of late-stage clinical programs and novel pipeline candidates.
We continue to expand our broad knowledge of mitochondrial biology and novel chemistries to advance our mitochondrial programs and pipeline candidates. We are a high-energy, innovative company with a hard-working team striving to further our mission of patient-focused therapeutics development.
To learn more about joining our team, please click on the links below to see current open positions at Stealth.
Note to Employment Agencies: Please do not forward agency résumés. Stealth BioTherapeutics is not responsible for any fees related to résumés that are unsolicited.